Sleep Disorder Ctr-Ft Walton is categorized under Hospitals in Crestview, FL and active since 2006.
Sleep Disorder Ctr-Ft Walton was established in 2006, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6219996 by the NAICS.
If you are seeking more information, feel free to contact Thomas Kelly, Owner at the company’s single location by writing to 502 East Pine Avenue, Crestview, Florida FL 32539 or by phoning (850) 689-5496. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sleep Disorder Ctr-Ft Walton |
| Contact Person: | Thomas Kelly, Owner |
| Address: | 502 East Pine Avenue, Crestview, Florida 32539 |
| Phone Number: | (850) 689-5496 |
| Website Address: | sdcfwb.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6219996 |
| Share This Business: |
Sleep Disorder Ctr-Ft Walton was started in 2006 to provide professional Hospitals under the SIC code 8062 and NAICS code 6219996. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Thomas Kelly, Owner for inquiries that concern Sleep Disorder Ctr-Ft Walton by calling the company number (850) 689-5496, as your correspondence is most welcome. Additionally, the physical location of the single location of Sleep Disorder Ctr-Ft Walton can be found at the coordinates 30.76356,-86.56829 as well as the street address 502 East Pine Avenue in Crestview, Florida 32539.
For its online presence, you may visit Sleep Disorder Ctr-Ft Walton’s website at sdcfwb.com and engage with its social media outlets through on Twitter and on Facebook.